Epoxyeicosanoid signaling in CNS function and disease
- 21 June 2009
- journal article
- review article
- Published by Elsevier BV in Prostaglandins & Other Lipid Mediators
- Vol. 91 (3-4), 68-84
- https://doi.org/10.1016/j.prostaglandins.2009.06.004
Abstract
No abstract availableKeywords
This publication has 149 references indexed in Scilit:
- Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathwaysProceedings of the National Academy of Sciences of the United States of America, 2008
- Identification of Novel Endogenous Cytochrome P450 Arachidonate Metabolites with High Affinity for Cannabinoid ReceptorsJournal of Biological Chemistry, 2008
- Differential subcellular distribution and colocalization of the microsomal and soluble epoxide hydrolases in cultured neonatal rat brain cortical astrocytesJournal of Neuroscience Research, 2008
- Antiangiogenic Effect of Inhibitors of Cytochrome P450 on Rats with Glioblastoma MultiformeJournal of Cerebral Blood Flow & Metabolism, 2008
- CYP2J2 and CYP2C8 polymorphisms and coronary heart disease risk: the Atherosclerosis Risk in Communities (ARIC) studyPharmacogenetics and Genomics, 2007
- Soluble Epoxide Hydrolase: A Novel Therapeutic Target in StrokeJournal of Cerebral Blood Flow & Metabolism, 2007
- Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs)Prostaglandins & Other Lipid Mediators, 2007
- Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitorsProceedings of the National Academy of Sciences of the United States of America, 2006
- Inhibition of soluble epoxide hydrolase reduces LPS-induced thermal hyperalgesia and mechanical allodynia in a rat model of inflammatory painLife Sciences, 2006
- Genetic variation in soluble epoxide hydrolase ( EPHX2 ) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) studyHuman Molecular Genetics, 2006